China Super Bug Growing Global Threat To ALL Humans

Professor Chen Sheng, a professor of Poly U’s Department of Applied Biology and Chemical Technology, has made a freighting new discovery.  An antibiotic resistant super bug is making its way across the country — the new deadly illness spreads quickly — the mainstream media remains tight lipped about this potential epidemic.

Scientists at the Hong Kong Polytechnic University in Hangzhou, China have discovered a new strain of antibiotic-resistant pneumonia which spreads incredibly fast, after a 2016 outbreak in a hospital ICU led to the deaths of five patients ranging in age from 53 to 73. In findings published in The Lancetresearchers conclude that the new superbug poses a “substantial threat to human health” due to the fact that it is “simultaneously hypervirulent, multidrug resistant, and highly transmissible.”

 

NPR reports:

The microbe can fight off all drugs available in China, Chen says. “We don’t have anything in China to stop it,” he says. “There is a drug available in the U.S. that should be effective against it, but we haven’t tested it yet.”

In the outbreak, the five patients who died were all older than 53. They were all on ventilators after undergoing major surgeries. And they died from severe lung failure, multiorgan failure or septic shock, the researchers found.

“The disease progresses very fast,” Chen says. “It starts in the lungs and then infects other organs, like the liver.”

 

The Lancet has titled their article: A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study.  It bears to reason that this may be something that the general public should be concerned about, and the silence by mainstream media is telling.

Scientists in Hangzhou, China have discovered a new strain of antibiotic-resistant pneumonia which spreads incredibly fast. They completed a study following a 2016 outbreak in a hospital ICU (intensive care unit) which led to the deaths of five patients ranging in age from 53 to 73.

According to Infowars, the findings in the published piece by The Lancet are obviously less than enticing. Researchers concluded that the triple-threat posed by this new superbug poses a “substantial threat to human health because they are simultaneously hypervirulent, multidrug resistant, and highly transmissible.”

K. pneumoniae  (ST11 CR-HvKP) is a deadly combination of two previously known strains of pneumonia; one which shrugs off all but the toughest antibiotics, and the other which is classified as “very severe” and “hypervirulent” in terms of lethality and how quickly it spreads.  And failure to control the spread of this super bug will make it a global epidemic. 

The new report also reveals that samples from several other areas of China were tested and came back positive for the new superbug. The researchers also stated clearly: “Control measures should be implemented to prevent further dissemination of such organisms.”  This means there’s a potential for a global outbreak if China cannot contain this new suber bug.

While Allergan’s U.S. approved antibiotic of last resort “Avibactam” can likely handle the ST11 CR-HvKP strain, yet the antibiotic is not available in China, which currently has nothing in its pharmaceutical arsenal to battle this particular infection. This is highly concerning to epidemiologists, Liang Chen and Barry Kreisworth. Both are calling the new strain of pneumoniae an “alarming evolutionary event.” According to Chen, “The microbe can fight off all drugs available in China. We don’t have anything in China to stop it. There is a drug available in the U.S. that should be effective against it, but we haven’t tested it yet.” Until China approves Avibactam or a similarly effective antibiotic of last resort, doctors and health officials can only prevent the spread of hypervirulent pneumonia by quickly identifying outbreaks and isolating the infected persons.

Chen went on to say “the disease progresses very fast. It starts in the lungs and then infects other organs, like the liver.” The five patients who have died from this strain were all older than 53. They were all on ventilators after undergoing major surgeries and they died from severe lung failure, multiorgan failure, or septic shock, the researchers found.

China Must approves Avibactam or a similarly effective antibiotic of last resort, doctors and health officials can only prevent the spread of this hypervirulent pneumonia by rapidly identifying outbreaks and isolating the infected immediately.

 

H/T ZeroHedge; Mac Slavo

Text Example

Share this article on Social Media by clicking the share buttons on screen, support our independent journalism! Get the word out!